- 2,079
How to Plan for the Obesity Drug Revolution | ThinkAdvisor
Life insurers and their reinsurers are starting to think about what Wegovy, Saxenda and successors could do for your clients.
www.thinkadvisor.com
Insurers and their reinsurers have seen enthusiasm about weight-loss wonder drugs come and go for decades, but now medical experts at Gen Re, Reinsurance Group of America, Munich Re, Scor and Swiss Re are starting let their guard down and wonder what might happen if the GLP-1 agonists really work, and keep working.